The effects of β-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and β-amyloid secretion

Neuroscience

Volumn 113, Issue 4, 2002, Pages 849-855

  Olivieri, G ^a   Novakovic, M ^a   Savaskan, E ^a   Meier, F ^a   Baysang, G ^a   Brockhaus, M ^b   Muller Spahn F ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

estradiol; amyloid; estradiol; Alzheimer's disease; Cobalt; Hydrogen peroxide; Mercury

Indexed keywords

17ALPHA ESTRADIOL; AMYLOID BETA PROTEIN; COBALT; ESTRADIOL; MERCURY;

ARTICLE; CELL STRAIN; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SECRETION;

AMYLOID BETA-PROTEIN; COBALT; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; GLUTATHIONE; HUMANS; MERCURY; METALS, HEAVY; NEUROBLASTOMA; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; TUMOR CELLS, CULTURED;

EID: 0037055996     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00211-7     Document Type: Article

References (59)

1. Azevedo R.B., Lacava Z.G., Miyasaka C.K., Chaves S.B., Curi R. Regulation of antioxidant enzyme activities in the male and female rat macrophages by sex steroids. Braz. J. Med. Biol. Res. 34:2001;683-687.
2. Bains J.S., Shaw C.A. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res. Rev. 25:1997;335-358.
3. Beato M. Gene regulation by steroid hormones. Cell. 56:1989;335-344.
4. Behl C., Skutella T., Lezoualc'h F., Post A., Widmann M., Newton C.J., Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51:1997;535-541.
5. Behl C., Widmann M., Trapp T., Holsboer F. 17Beta-estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216:1995;473-482.
6. Benzi G., Moretti A. Are reactive oxygen species involved in Alzheimer's disease? Neurobiol. Aging. 16:1995;661-674.
7. Brinton R.D., Tran J., Proffitt P., Montoya M. 17-Beta-estradiol enhances the outgrowth and survival of neocortical neurons in culture. Neurochem. Res. 22:1997;1339-1351.
8. Butterfield D.A., Hensley K., Harris M., Mattson M., Carney J. beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200:1994;710-715.
9. Clark J.H., Williams M., Upchurch S., Eriksson H., Helton E., Markaverich B.M. Effects of estradiol-17α on nuclear occupancy of the estrogen receptor, stimulation of nuclear type II sites, and uterine growth. J. Steroid Biochem. 16:1982;323-328.
10. Cornett C.R., Markesberry W.R., Ehmann W.D. Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology. 19:1998;339-346.
11. del Rio L.A., Sandalio L.M., Palma J.M., Bueno P., Corpas F.J. Metabolism of oxygen radicals in peroxisomes and cellular implications. Free Radical Biol. Med. 13:1992;557-580.
12. Dodel R.C., Du Y., Bales K.R., Gao F., Paul S.M. Sodium salicylate and 17β-estradiol attenuate nuclear transcription factor NF-κB translocation in cultured rat astroglial cultures following exposure to amyloid Aβ1-40 and lipopolxsaccharides. J. Neurochem. 73:1999;1453-1460.
13. Dubal D.B., Shughrue P.J., Wilson M.E., Merchenthaler I., Wise P.M. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J. Neurosci. 19:1999;6385-6393.
14. Edstrom A., Mattson H. Inhibition and stimulation of rapid axonal transport in vitro by sulfhydral blockers. Brain Res. 108:1976;381-395.
15. Ehmann W.D., Markesbery W.R., Alauddin M., Hossain T.I.M., Brubaker E.H. Brain trace elements in Alzheimer's disease. Neurotoxicology. 7:1986;197-206.
16. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
17. Gandy S., Almeida O.P., Fonte J., Lim D., Waterrus A., Spry N., Flicker L., Martins R.N. Chemical andropause and amyloid β-peptide. J. Am. Med. Assoc. 285:2001;2261-2262.
18. Green P.S., Gridley K.E., Simpkins J.W. Nuclear estrogen receptor-independent neuroprotectiuon by estratrienes: a novel interpretation with glutathione. Neuroscience. 84:1998;7-10.
19. Green P.S., Simpkins J.W. Estrogens and estrogen-like non-feminizing compounds. Their role in the prevention and treatment of Alzheimer's disease. Ann. NY Acad. Sci. 924:2000;93-98.
20. Gu Q., Korach K.S., Moss R.L. Rapid action of 17beta-estradiol on kainate-induced currents in hippocampal neurons lacking intracellular estrogen receptors. Endocrinology. 140:1999;660-666.
21. Hammond J., Le Q., Goodyer C., Gelfand M., Trifiro M., LeBlanc A. Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons. J. Neurochem. 77:2001;1319-1326.
22. Henderson V.W. Estrogen, cognition, and a woman's risk of Alzheimer's disease. CNS Drugs. 8:1997;343-351.
23. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 91:1994;3270-3274.
24. Hock C., Drasch G., Golombowski S., Müller-Spahn F., Willershausen-Zönnchen B., Schwarz P., Hock U., Growdon J.H., Nitsch R.M. Increased blood mercury levels in patients with Alzheimer's disease. J. Neural Transm. 105:1998;59-68.
25. Hung A.Y., Haass C., Nitsch R.M., Qiu W.Q., Citron M., Wurtman R.J., Growdon J.H., Selkoe D.J. Activation of protein kinase C inhibits cellular production of the amyloid beta protein. J. Biol. Chem. 268:1993;22959-22962.
26. Kneifel M.A., Leytus S.P., Fletcher E., Weber T., Mangel W.F., Katzenellenbogen B.S. Uterine plasminogen activator: modulation by steroid hormones. Endocrinology. 111:1982;493-499.
27. Korenman S.G. Comparative binding affinities of estrogen and its relation to estrogenic potency. Steroids. 13:1969;163-177.
28. Larson G.H., Wise P.M. Constitutive and regulated prolactin secretion: effects of estradiol. Biol. Reprod. 50:1994;357-362.
29. Lubahn D.B., McCarty K.S. Jr., McCarty K.S. Sr. Electrophoretic characterization of purified bovine, porcine, murine, rat and human uterine estrogen receptors. J. Biol. Chem. 260:1985;2515-2526.
30. Marino M., Pallottini V., Trentalance A. Estrogens cause rapid activation of IP3-PKC-alpha signal transduction pathway in HEPG2 cells. Biochem. Biophys. Res. Commun. 245:1998;254-258.
31. Martin G.M., Austad S.N., Johnson T.E. Genetic analysis of aging: role of oxidative and environmental stresses. Nature Genet. 13:1996;25-34.
32. Mattson M.P., Goodman Y. Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium. Brain Res. 676:1995;219-224.
33. Mattson M.P., Robinson N., Guo Q. Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. NeuroReport. 8:1997;3817-3821.
34. Meyer R.G., Cornelius R. Cobalt(III)-promoted hydrolysis of ATP. J. Inorg. Biochem. 22:1984;249-258.
35. Moosmann B., Behl C. The antioxidant neuroprotective effects of estrogens and phenolic compounds and independent from their estrogenic properties. Proc. Natl. Acad. Sci. USA. 96:1999;8867-8872.
36. Mosior M., Epand M. Mechanisms of activation of protein kinase C: roles of diolen and phosphatidylserine. Biochemistry. 32:1993;66-75.
37. Murakoshi M., Ikada R., Tagawa M. Regulation of prostatic glutathione-peroxidase in rats treated with a combination of testosterone and 17beta-estradiol. J. Toxicol. Sci. 24:1999;415-420.
38. Murthy P.R., Dimattia G.E., Friesen H.G. Role of calcium in prolactin-stimulated c-myc gene expression and mitogenesis in NB2 lymphoma cell. Endocrinology. 122:1988;2476-2485.
39. Nitsch R.M., Deng M., Growdon J.H., Wurtman R.J. Serotonin 5-HT2a receptors stimulate amyloid precursor protein ectodomain secretion. J. Biol. Chem. 271:1996;4188-4194.
40. Olivieri G., Baysang G., Meier F., Müller-Spahn F., Stähelin H.B., Brockhaus M., Brack Ch. N-acetyl-cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: effects on β-amyloid secretion and tau phosphorylation. J. Neurochem. 76:2001;224-233.
41. Olivieri G., Brack Ch., Müller-Spahn F., Stähelin H.B., Herrmann M., Renard P., Brockhaus M., Hock C. Mercury induces cell cytotoxicity, oxidative stress and increases β-amyloid secretion, tau-phosphorylation in SHSY5Y neuroblastoma cells. J. Neurochem. 74:2000;231-236.
42. Olivieri G., Hess C., Savaskan E., Ly C., Meier F., Baysang G., Brockhaus M., Müller-Spahn F. Melatonin protects SHSY5Y neuroblastoma cells from cobalt induced oxidative stress, neurotoxicity and increased β-amyloid secretion. J. Pineal Res. 31:2001;320-325.
43. Pacifici R.E., Davies K.J.A. Protein, lipid and DNA repair systems in oxidative stress: the free-radical theory of aging revisited. Gerontology. 37:1991;166-180.
44. XL expression and β-amyloid-induced apoptosis: relevance to Alzheimer's disease. J. Neurochem. 72:1999;1552-1563.
45. Rajanna B., Chetty C.S., Rajanna S., Hall E., Fail S., Yallapragada P.R. Modulation of protein kinase C by heavy metals. Toxicol. Lett. 81:1995;197-203.
46. Scammell J.G., Burrage T.G., Dannies P.S. Hormonal induction of secretory granules in a pituitary tumor cell line. Endocrinology. 119:1986;1543-1548.
47. Selkoe D.J. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell. Biol. 10:1994;373-403.
48. Sherwin B.B. Estrogen effects on cognition in menopausal women. Neurology. 48:1997;S21-S26.
49. Simpkins J.W., Green P.S., Gridley K.E., Singh M., de Fiebre N.C., Rajakumar G. Role of estrogen replacement therapy in memory enhancement and preventionnof neuronal loss associated with Alzheimer's disease. Am. J. Med. 103:1997;S19-S25.
50. Stone D.J., Rozovsky I., Morgan T.E., Anderson C.P., Finch C.E. Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: Implications for Alzheimer's disease. J. Neurosci. 18:1998;3180-3185.
51. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gueland B., Andrews H., Mayeux R. Effect of estrogen during menopause on risk and age of Alzheimer's disease. Lancet. 348:1996;429-432.
52. Thompson C.M., Markesbery W.R., Ehmann W.D., Mao Y.X., Vance D.E. Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology. 9:1988;1-8.
53. Toborek M., Hennig B. Fatty acid-mediated effects on the glutathione redox cycle in cultured endothelial cells. Am. J. Clin. Nutr. 59:1994;60-65.
54. Wang C.N., Chi C.W., Lin Y.L., Chen C.F., Shiao Y.J. The neuroprotective effects of Phytoestrogens on amyloid β protein-induced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons. J. Biol. Chem. 276:2001;5287-5295.
55. Watters J.J., Dorsa D.M. Transcriptional effects of estrogen on neuronal neurotensin gene expression involve cAMP/protein kinase A-dependent signaling mechanisms. J. Neurosci. 18:1998;6672-6680.
56. Wetzel C.H.R., Hermann B., Behl C., Pestel E., Rammes G., Ziegelgänsberg W., Holsboer F., Rupprecht R. Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor. Mol. Endocrinol. 12:1998;1441-1451.
57. Xu H., Gouras G.K., Greenfield J.P., Vincent B., Naslund J., Mazzarelli L., Fried G., Jovanovic J.N., Seeger M., Relkin N.R., Liao F., Checler F., Buxbaum J.D., Chait B.T., Thinakaran G., Sisodia S.S., Wang R., Greengard P., Gandy S. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat. Med. 4:1998;447-451.
58. Yaffe K., Sawaya G., Liebenburg I., Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. J. Am. Med. Assoc. 279:1998;688-695.
59. Yamamoto H., Tang H. Effect of melatonin, piperonyl butoxide, or cobalt chloride on l-cysteine-induced lipid peroxidation in homogenate from whole brain of mice. Toxicol. Lett. 89:1996;51-56.